{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:50:51Z","timestamp":1772578251150,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ijantimicag.2013.07.015","type":"journal-article","created":{"date-parts":[[2013,9,7]],"date-time":"2013-09-07T10:15:45Z","timestamp":1378548945000},"page":"580-583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Strongyloides disseminated infection successfully treated with parenteral ivermectin: case report with drug concentration measurements and review of the literature"],"prefix":"10.1016","volume":"42","author":[{"given":"Katia","family":"Donadello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Cristallini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio Silvio","family":"Taccone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Lorent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"de Backer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0005","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.amjmed.2006.05.072","article-title":"Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey","volume":"120","author":"Boulware","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/01.mcg.0000152779.68900.33","article-title":"Intestinal strongyloidiasis: recognition, management, and determinants of outcome","volume":"39","author":"Concha","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0015","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","article-title":"Human T-lymphotropic virus 1: recent knowledge about an ancient infection","volume":"7","author":"Verdonck","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0020","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/S0140-6736(07)60945-3","article-title":"Colitis in an alcohol-dependent woman","volume":"369","author":"Oude Lashof","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0025","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1469-0691.2006.01443.x","article-title":"Severe strongyloidiasis in corticosteroid-treated patients","volume":"12","author":"Fardet","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0030","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2334-13-78","article-title":"Severe strongyloidiasis: a systematic review of case reports","volume":"13","author":"Buonfrate","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0035","first-page":"341","article-title":"Thiabendazole for the control of Strongyloides stercoralis infection in a hyperendemic area in Peru [in Spanish]","volume":"25","author":"Marcos","year":"2005","journal-title":"Rev Gastroenterol Peru"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-7961-4-8","article-title":"Intestinal strongyloidiasis and hyperinfection syndrome","volume":"4","author":"Vadlamudi","year":"2006","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0045","first-page":"558","article-title":"Parasitic pulmonary disease","volume":"126","author":"Barrett-Connor","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0050","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0016-5107(03)02280-6","article-title":"Endoscopic and histopathologic findings of Strongyloides stercoralis infection in a patient with AIDS","volume":"58","author":"Overstreet","year":"2003","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0055","doi-asserted-by":"crossref","first-page":"e1044","DOI":"10.1371\/journal.pntd.0001044","article-title":"Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis","volume":"5","author":"Suputtamongkol","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0060","doi-asserted-by":"crossref","first-page":"e1254","DOI":"10.1371\/journal.pntd.0001254","article-title":"Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis","volume":"5","author":"Bisoffi","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0065","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/QCO.0b013e3283551dbd","article-title":"Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis","volume":"25","author":"Mejia","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0070","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/818296","article-title":"Fatal outcome of disseminated strongyloidiasis despite detectable plasma and cerebrospinal levels of orally administered ivermectin","volume":"2009","author":"Rose","year":"2009","journal-title":"J Parasitol Res"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1399-3062.2009.00386.x","article-title":"Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient","volume":"11","author":"Huston","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(99)02744-0","article-title":"Parenteral ivermectin in Strongyloides hyperinfection","volume":"355","author":"Chiodini","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0085","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1086\/430827","article-title":"Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin","volume":"41","author":"Marty","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0090","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s15010-005-5060-x","article-title":"Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin","volume":"33","author":"Hauber","year":"2005","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0095","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00134-005-2725-y","article-title":"Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock","volume":"31","author":"Salluh","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4269\/ajtmh.2005.73.122","article-title":"Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report","volume":"73","author":"Pacanowski","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-2407-6-87","article-title":"An unusual cause of alveolar hemorrhage post hematopoietic stem cell transplantation: a case report","volume":"6","author":"Gupta","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1399-3062.2008.00358.x","article-title":"Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin","volume":"11","author":"Lichtenberger","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0115","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4269\/ajtmh.2008.79.853","article-title":"Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection","volume":"79","author":"Leung","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0120","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/00365540903443165","article-title":"Serum ivermectin levels after enteral and subcutaneous administration for Strongyloides hyperinfection: a case report","volume":"42","author":"Grein","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0125","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/TP.0b013e3182115b7b","article-title":"Donor-derived Strongyloides stercoralis infections in renal transplant recipients","volume":"91","author":"Hamilton","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0130","unstructured":"US Food and Drug Administration. Stromectol\u00ae (Ivermectin). FDA; 2010. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/050742s022lbl.pdf [accessed April 2013]."},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0135","doi-asserted-by":"crossref","first-page":"911","DOI":"10.4269\/ajtmh.2005.73.911","article-title":"Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis","volume":"73","author":"Turner","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0140","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4269\/ajtmh.2010.10-0258","article-title":"Non-oral treatment with ivermectin for disseminated strongyloidiasis","volume":"83","author":"Fusco","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0145","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/009127002401382731","article-title":"Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects","volume":"42","author":"Guzzo","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2013.07.015_bib0150","series-title":"Ivermectin and abamectin","first-page":"113","article-title":"Pharmacokinetics of ivermectin in animals and humans","author":"Fink","year":"1989"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913002872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913002872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T11:53:27Z","timestamp":1563882807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857913002872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0924857913002872"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.07.015","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strongyloides disseminated infection successfully treated with parenteral ivermectin: case report with drug concentration measurements and review of the literature","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and the International Society of Chemotherapy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}